Natural Health Trends Corp. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; comparisons are with the three months ended March 31, 2023 unless stated otherwise. Financial amounts are in U.S. dollars; statement amounts are in thousands unless noted.
Business context
Natural Health Trends is an international direct-selling and e-commerce company selling personal care, wellness and “quality of life” products under the NHT Global brand. It had 31,620 active members at March 31, 2024, down from 32,410 at December 31, 2023 and 38,330 a year earlier. Hong Kong generated 83.8% of quarterly sales; substantially all Hong Kong sales are products delivered to members in China.
Financial performance and liquidity
| Metric | Q1 2024 | Q1 2023 / comparison |
|---|---|---|
| Net sales | $10.951 million | $11.861 million; down 8% |
| Gross profit / margin | $8.039 million / 73.4% | $8.830 million / 74.5% |
| Operating loss | $365,000 | $394,000 |
| Other income, net | $563,000 | $681,000 |
| Net income | $188,000; $0.02 per diluted share | $257,000; $0.02 per diluted share |
| Operating cash flow | $549,000 provided | $696,000 used |
| Cash, cash equivalents and marketable securities | $54.4 million at March 31, 2024 | Down $1.7 million from December 31, 2023 |
| Working capital | $41.9 million; current ratio 3.0 | Working capital down $2.4 million from year-end |
Commissions were $4.486 million (41.0% of sales), versus $4.992 million (42.1%). Selling, general and administrative expenses were $3.918 million, down from $4.232 million. The company reported no borrowings in the presented balance sheet; liabilities include $3.418 million of operating lease obligations and $9.0 million of income taxes payable related to the Tax Act repatriation tax ($5.1 million noncurrent).
Material changes and drivers
- Sales fell $910,000. Hong Kong sales declined 5% to $9.174 million; sales outside Hong Kong declined 19%.
- Management attributed the Hong Kong sales comparison primarily to deferred revenue timing: promotions led to more orders received but not shipped by quarter-end. Management said order volume was slightly higher than in Q1 2023. Deferred revenue was $7.174 million at quarter-end, including $5.480 million for unshipped orders and unredeemed vouchers.
- Gross margin declined, reflecting lower administrative-fee revenue and higher costs for Premium Noni Juice. Lower commissions outside Hong Kong and reduced employee-related costs and professional fees partially offset revenue pressure.
- Net income decreased 27%, also reflecting lower other income; the prior-year period included Hong Kong-dollar intercompany currency gains that did not recur.
- Cash and cash equivalents declined substantially, but the company purchased $28.5 million of marketable securities with maturities greater than three months. The resulting investing cash outflow largely reflects moving funds into investments, rather than an equivalent reduction in total cash and securities.
Outlook, risks and notable items
- No specific earnings or revenue guidance was provided. Management believes existing liquidity and operating cash flows should fund normal operations and commitments for the foreseeable future.
- Management expects to continue quarterly dividends of $0.20 per share for the foreseeable future, subject to board discretion. A further $0.20 dividend was declared April 29, 2024, payable May 24 to holders of record May 14.
- The company’s results are highly exposed to Hong Kong and China, including political and social conditions, consumer sentiment, foreign exchange, and regulatory requirements. It does not currently hold a China direct-selling license and cannot predict if or when one may be obtained.
- Management cited risks including declining membership, direct-selling and product regulation, dependence on third-party manufacturers, competition, currency movements, and its history of negative annual operating cash flows in 2022 and 2023. It said no material risk-factor changes occurred since the 2023 Form 10-K.
- No legal proceedings were reported. The company declared and paid $0.20 per share in Q1, totaling $2.3 million. It had $21.9 million remaining under its share repurchase authorization, inclusive of related estimated income tax.
- Management concluded disclosure controls were effective as of March 31, 2024; no material changes in internal control over financial reporting were reported.
Important facts for investors to verify
- Whether deferred revenue converts into recognized sales as expected, and whether order volume and active-member trends stabilize.
- Whether Hong Kong/China concentration and China regulatory conditions materially affect sales, operations or the potential for a direct-selling license.
- Whether operating cash generation remains positive after working-capital timing effects and recurring dividends.
- Composition, maturity profile and valuation of the $45.5 million of available-for-sale investments; $3.6 million of cash was held in China subject to foreign-currency controls.
- Ability to sustain the dividend alongside the $9.0 million repatriation-tax liability and other commitments.